TY - JOUR
T1 - Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome
AU - Le, Lu Q.
AU - Kabarowski, Janusz H.S.
AU - Weng, Zhigang
AU - Satterthwaite, Anne B.
AU - Harvill, Eric T.
AU - Jensen, Eric R.
AU - Miller, Jeff F.
AU - Witte, Owen N.
PY - 2001
Y1 - 2001
N2 - Mice with a targeted disruption of the gene encoding a lymphoid-expressed orphan G protein-coupled receptor, G2A, demonstrate a normal pattern of T and B lineage differentiation through young adulthood. As G2A-deficient animals age, they develop secondary lymphoid organ enlargement associated with abnormal expansion of both T and B lymphocytes. Older G2A-deficient mice (>1 year) develop a slowly progressive wasting syndrome, characterized by lymphocytic infiltration into various tissues, glomerular immune complex deposition, and anti-nuclear autoantibodies. G2A-deficient T cells are hyperresponsive to TCR stimulation, exhibiting enhanced proliferation and a lower threshold for activation. Our findings demonstrate that G2A plays a critical role in controlling peripheral lymphocyte homeostasis and that its ablation results in the development of a novel, late-onset autoimmune syndrome.
AB - Mice with a targeted disruption of the gene encoding a lymphoid-expressed orphan G protein-coupled receptor, G2A, demonstrate a normal pattern of T and B lineage differentiation through young adulthood. As G2A-deficient animals age, they develop secondary lymphoid organ enlargement associated with abnormal expansion of both T and B lymphocytes. Older G2A-deficient mice (>1 year) develop a slowly progressive wasting syndrome, characterized by lymphocytic infiltration into various tissues, glomerular immune complex deposition, and anti-nuclear autoantibodies. G2A-deficient T cells are hyperresponsive to TCR stimulation, exhibiting enhanced proliferation and a lower threshold for activation. Our findings demonstrate that G2A plays a critical role in controlling peripheral lymphocyte homeostasis and that its ablation results in the development of a novel, late-onset autoimmune syndrome.
UR - http://www.scopus.com/inward/record.url?scp=0035020493&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035020493&partnerID=8YFLogxK
U2 - 10.1016/S1074-7613(01)00145-5
DO - 10.1016/S1074-7613(01)00145-5
M3 - Article
C2 - 11371358
AN - SCOPUS:0035020493
SN - 1074-7613
VL - 14
SP - 561
EP - 571
JO - Immunity
JF - Immunity
IS - 5
M1 - 143
ER -